Product Images Talzenna

The text describes a chart that shows the progression-free survival probability over time for the medication TALZENNA in comparison to chemotherapy. The chart shows the number of patients at risk, and the time is measured in months. The number of patients at risk decreases over time for both treatments.*

This is a description of a pharmaceutical product or drug that is distributed by Pfizer Laboratories, which is a division of Pfizer Inc., located in New York, NY with a zip code of 10017.*

This text indicates that the item is distributed by Pfizer Labs, which is a division of Pfizer Inc located in New York City with a zip code of 10017.*

This text is a product label for Talzenna capsules containing 1mg of talazoparib. It provides instructions for storage temperature, dosage, and usage as well as warnings to keep out of reach of children. It is distributed by U.S. Pharmaceuticals and is available only by prescription.*

Talzenna® is a medication available in capsule form which contains talazoparib. These capsules are not available for sale and are provided as a professional sample only. Each capsule contains ampoules which are equivalent to 453 g of talazoparib tosyfate. The capsules are distributed by U.S. Pharmaceuticals and are made in Germany. The dosage and usage instructions can be found in the accompanying prescribing information. The lot/exp number is not readable from the text.*